ASPN Form 4: 11,673 RSUs, 16,416 options, 23,347 PSUs detailed
Rhea-AI Filing Summary
Glenn E. Deegan, Chief Administrative Officer, General Counsel and Corporate Secretary of Aspen Aerogels, Inc. (ASPN), reported equity awards granted on 09/30/2025. The filing shows 11,673 RSUs, 16,416 stock options with a $6.96 exercise price and a 09/30/2035 expiration, and 23,347 performance share units (PSUs). The RSUs and options each vest in three equal annual tranches on 09/30/2026, 09/30/2027 and 09/30/2028. The PSUs vest on 03/05/2028 following a performance period from 01/01/2025 to 12/31/2027, and payout ranges from 0% to 200% of target based on total shareholder return relative to the Russell 2000 components. The reported beneficial ownership counts after the transactions are 11,673 RSUs, 16,416 options, and 23,347 PSUs.
Positive
- 23,347 PSUs awarded with payout range 0%–200% tied to TSR vs Russell 2000
- 16,416 stock options with a $6.96 exercise price and 09/30/2035 expiration (long-dated)
- Time-based vesting for RSUs and options in three equal tranches through 09/30/2028
Negative
- None.
Insights
Equity awards combine time-based and performance-based vesting to align pay with multi-year results.
The reporting shows 11,673 RSUs and 16,416 options that vest in three equal tranches on 09/30/2026, 09/30/2027 and 09/30/2028, which ties retention to a three-year period.
The 23,347 PSUs vest on 03/05/2028 after a performance period from 01/01/2025 to 12/31/2027 with payout between 0% and 200% based on total shareholder return versus the Russell 2000, explicitly linking a portion of pay to relative market performance.
The filing discloses standard executive grant mechanics and a decade-long option term.
The stock options carry an exercise price of $6.96 and expire on 09/30/2035, providing a long exercise window.
All disclosed awards are held directly by the reporting person, and the filing is executed by an attorney-in-fact, confirming procedural compliance with Section 16 reporting requirements.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Options (Right to Buy) | 16,416 | $0.00 | -- |
| Grant/Award | Performance Share Units | 23,347 | $0.00 | -- |
| Grant/Award | Common Stock | 11,673 | $0.00 | -- |
Footnotes (1)
- Each Restricted Stock Unit ("RSU") represents the right to receive one share of Common Stock upon vesting. The RSUs vest as to one-third of the shares on September 30, 2026, an additional one-third of the shares on September 30, 2027 and the remaining one-third of the shares on September 30, 2028. Represents 11,673 RSUs. The options vest as to one-third of the shares on September 30, 2026, an additional one-third of the shares on September 30, 2027 and the remaining one-third of the shares on September 30, 2028. Each performance share unit ("PSU") represents a contingent right to receive one share of Common Stock upon vesting. The PSUs vest on March 5, 2028, following the completion of the performance period, which begins on January 1, 2025 and ends on December 31, 2027. Ranging between 0-200% of the target number of PSUs (as reflected in Table II above), the PSUs vest based on the total shareholder return of Common Stock relative to the total stockholder return of the components of the Russell 2000 Index.
